Characteristics of CAM users and non-CAM users (N = 546).
收藏数据链接：
官方服务：
资源简介：
a Other ethnic groups were excluded from the analysisb FEC (5-fluorouracil/5-FU, epirubicin and cyclophosphamide), FAC (5-FU, doxorubicin and cyclophosphamide), CMF (cyclophosphamide, methotrexate and 5FU), AC (doxorubicin and cyclophosphamide)c Fisher’s exact testd An adaptation of the 16-item Side Effect Burden Scale [35] was used to measure patients’ symptom burden. K-means clustering was used to divide patients into 2 clusters of high and low total symptom burden.* Significance level at p **Significance level at p ***Significance level at p Characteristics of CAM users and non-CAM users (N = 546).
创建时间：
2015-12-03
